PULMONARY VEIN OCCLUSION

PULMONARY VEIN OCCLUSION was reported 81 times

PULMONARY VEIN OCCLUSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vasopressin V2 Receptor Antagonist [EPC] 9 0.0006
1 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 1 0.0003
2 CD33-directed Immunoconjugate [EPC] 1 0.0003
3 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
4 Prostacyclin Receptor Agonist [EPC] 4 0.0002
5 Phosphodiesterase 5 Inhibitor [EPC] 16 0.0001
6 Antimalarial [EPC] 1 0.0001
7 Antiprotozoal [EPC] 1 0.0001
8 Soluble Guanylate Cyclase Stimulator [EPC] 3 0.0001
9 Barbiturate [EPC] 1 0.0001
10 Melatonin Receptor Agonist [EPC] 1 0.0001
11 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
12 Endothelin Receptor Antagonist [EPC] 13 0.0001
13 Orexin Receptor Antagonist [EPC] 1 0.0001
14 Aldosterone Antagonist [EPC] 8 0.0001
15 Antimetabolite Immunosuppressant [EPC] 1 0.0000
16 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
17 Loop Diuretic [EPC] 20 0.0000
18 Bile Acid [EPC] 1 0.0000
19 Androgen [EPC] 1 0.0000
20 Methylxanthine [EPC] 2 0.0000
21 Angiotensin Converting Enzyme Inhibitor [EPC] 4 0.0000
22 Penem Antibacterial [EPC] 1 0.0000
23 Polyene Antifungal [EPC] 1 0.0000
24 Osmotic Laxative [EPC] 7 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 4 0.0000
26 Central Nervous System Stimulant [EPC] 2 0.0000
27 Aminoglycoside Antibacterial [EPC] 1 0.0000
28 Muscle Relaxant [EPC] 1 0.0000
29 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
30 Macrolide Antimicrobial [EPC] 1 0.0000
31 Glycopeptide Antibacterial [EPC] 1 0.0000
32 Nitroimidazole Antimicrobial [EPC] 1 0.0000
33 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
34 Prostacycline Vasodilator [EPC] 2 0.0000
35 Potassium Channel Blocker [EPC] 1 0.0000
36 Cardiac Glycoside [EPC] 1 0.0000
37 Androgen Receptor Inhibitor [EPC] 1 0.0000
38 HMG-CoA Reductase Inhibitor [EPC] 5 0.0000
39 Azole Antifungal [EPC] 2 0.0000
40 Alkylating Drug [EPC] 3 0.0000
41 Nitrate Vasodilator [EPC] 1 0.0000
42 Factor Xa Inhibitor [EPC] 3 0.0000
43 Platelet Aggregation Inhibitor [EPC] 6 0.0000
44 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
45 RANK Ligand Inhibitor [EPC] 2 0.0000
46 5-alpha Reductase Inhibitor [EPC] 1 0.0000
47 Expectorant [EPC] 2 0.0000
48 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
49 Atypical Antipsychotic [EPC] 4 0.0000
50 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
51 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
52 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
53 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
54 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
55 Opioid Agonist [EPC] 2 0.0000
56 alpha-Adrenergic Blocker [EPC] 1 0.0000
57 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
58 Proton Pump Inhibitor [EPC] 4 0.0000
59 Calcium [EPC] 1 0.0000
60 Vitamin D [EPC] 2 0.0000
61 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
62 Corticosteroid [EPC] 8 0.0000
63 Vitamin B12 [EPC] 2 0.0000
64 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
65 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
66 Vitamin C [EPC] 2 0.0000
67 Kinase Inhibitor [EPC] 2 0.0000
68 beta-Adrenergic Blocker [EPC] 1 0.0000
69 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
70 Benzodiazepine [EPC] 2 0.0000
71 GLP-1 Receptor Agonist [EPC] 1 0.0000